AFM13 in patients with CD30 positive relapsed or refractory (R/R) peripheral T cell lymphoma (PTCL): Results from the phase 2 redirect study Meeting Abstract


Authors: Kim, W. S.; Shortt, J.; Zinzani, P. L.; Mikhaylova, N.; Marin‐Niebla, A.; Radeski, D.; Ribrag, V.; Domenech, E. D.; Sawas, A.; Alexis, K.; Emig, M.; Garcia, L.; Overesch, A.; Pietzko, K.; Horwitz, S.
Abstract Title: AFM13 in patients with CD30 positive relapsed or refractory (R/R) peripheral T cell lymphoma (PTCL): Results from the phase 2 redirect study
Meeting Title: 17th International Conference on Malignant Lymphoma (ICML)
Journal Title: Hematological Oncology
Volume: 41
Issue: Suppl. 2
Meeting Dates: 2023 Jun 13-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2023-06-01
Start Page: 195
End Page: 196
Language: English
DOI: 10.1002/hon.3163_126
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 126 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz